Evidence map›Paper›PMID 41965776›Full record

ArticleAIDS research and therapy2026

Determinants of immune recovery and survival in HIV late presenters: a retrospective cohort study from Southwest China.

Die Li, Tongping Ren, Mei Liu, Jianjian Li, Meilin Li, Yungui Zhang, Rongjing Dong, Youwang Lu

Abstract read
In one paragraph

Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Die Li *School of Public Health, Dali University, Dali, 671000, Yunnan, China.
Tongping Ren *School of Public Health, Kunming Medical University, Kunming, 650500, Yunnan, China.
Mei LiuYunnan Provincial Hospital of Infectious Disease/Yunnan AIDS Care Center, Kunming, 650300, Yunnan, China.
Jianjian LiYunnan Provincial Hospital of Infectious Disease/Yunnan AIDS Care Center, Kunming, 650300, Yunnan, China.
Meilin LiYunnan Provincial Hospital of Infectious Disease/Yunnan AIDS Care Center, Kunming, 650300, Yunnan, China.
Yungui ZhangYunnan Provincial Hospital of Infectious Disease/Yunnan AIDS Care Center, Kunming, 650300, Yunnan, China. 805903562@qq.com.
Rongjing DongDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China. rongjingdong2009@163.com.
Youwang LuYunnan Provincial Hospital of Infectious Disease/Yunnan AIDS Care Center, Kunming, 650300, Yunnan, China. youwanglu@163.com.

Funding

535 Talents Program 2024-535Q01National Science and Technology Major Project for the Prevention and Control of Emerging and Major Infectious Diseases 2025ZD01905100Scientific Research Fund Project of Yunnan Provincial Department of Education 2024J0389Scientific Research Special Fund for Newly Recruited PhDs 2024BS002Special Project of Yunnan Provincial Clinical Research Center for Infectious Diseases 202405AJ310002the National Natural Science Foundation of China 82203934the Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Projec 2025ZD01905005the Talent Introduction Project of Yunnan Provincial Infectious Disease Hospital 3000005103Yunnan Provincial Clinical Medicine Center 2024YNLCYXZX0027
6 · The paper itself

Abstract

backgroundLate presentation (LP) of HIV infection, defined as diagnosis at an advanced stage with a low CD4⁺ T cell count or the presence of AIDS-defining illnesses, remains a major global challenge. Late presenters often experience higher morbidity, poorer immune recovery, and increased mortality, highlighting the importance of early diagnosis and timely initiation of antiretroviral therapy (ART).

methodsA retrospective analysis was conducted among HIV-infected patients who initiated ART at Yunnan Provincial Infectious Disease Hospital between 2004 and 2024. Late presenters were defined as patients with a baseline CD4⁺ T cell count < 350/µL or the presence of AIDS-defining illnesses, regardless of CD4⁺ T cell count. Clinical data were collected, survival rates were analyzed using the Kaplan–Meier method, and Cox regression and logistic regression were applied to identify associated factors.

resultsA total of 7,549 patients were included, with a median follow-up time of 10.0 years (IQR 5.7–13.6). Among them, 73.3% were late presenters. Compared with non-late presenters, late presenters had a higher risk of mortality and poorer immune recovery. Key factors influencing immune recovery included sex, baseline CD4⁺ T cell count, and baseline viral load, with baseline CD4⁺ T cell count being particularly important.

conclusionLate presentation of HIV infection significantly affects survival and immune reconstitution. This study highlights the importance of early diagnosis and intervention and provides evidence for identifying high-risk populations.

Indexed as

HIV InfectionsImmune ReconstitutionAdultAnti-HIV AgentsCD4 Lymphocyte CountChinaFemaleHumansMaleMiddle AgedRetrospective StudiesViral LoadAnti-HIV AgentsHIVImmune recoveryLate presentationSurvival rate

Identifiers

PMID41965776
PMCPMC13270822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.